טוען...
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
PURPOSE: A case-control study from two randomised breast cancer prevention trials of tamoxifen and raloxifene (P-1 and P-2) identified single nucleotide polymorphisms (SNPs) in or near genes ZNF423 and CTSO as factors which predict which women will derive most anti-cancer benefit from selective oest...
שמור ב:
| הוצא לאור ב: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4977422/ https://ncbi.nlm.nih.gov/pubmed/27400912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3885-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|